Psychiatry · Tamarac, FL
NPI
1467515361
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7431 N University Dr, Suite 204
Tamarac, FL, 33321
Phone (954) 720-7999
Groups this clinician bills Medicare through
Medicare paid, 2024
$129K
1,794 services
Medicare patients, 2024
387
Average age 75
Drug cost, 2024
$742K
7,701 prescriptions
Company payments, 2025
$2,629
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel E Chervony was code 99213 (office e&m - established), 696 times for 199 patients. In total Daniel E Chervony billed 1,794 services in 13 codes, and Medicare paid $129K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 696 | 199 | $65.14 | $45K |
| 99231 Hospital E&M - Subsequent | Facility | 435 | 141 | $39.94 | $17K |
| 99214 Office E&M - Established | Office | 358 | 119 | $96.52 | $35K |
| 99222 Hospital E&M - Initial | Facility | 116 | 104 | $104.52 | $12K |
| 99223 Hospital E&M - Initial | Facility | 76 | 74 | $139.18 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 52 | 35 | $63.39 | $3,296 |
| 90792 Psychotherapy - Nongroup | Office | 29 | 29 | $144.01 | $4,176 |
By year: 2022 $139K for 2,057 services; 2023 $137K for 1,798 services; 2024 $129K for 1,794 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel E Chervony prescribed most often to Medicare patients was Quetiapine Fumarate, with 675 prescriptions and refills. In total Daniel E Chervony wrote 7,701 Medicare prescriptions that cost $742K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 675 | 1,091 | 108 | $15K |
| Alprazolam Generic | 623 | 742 | 112 | $3,810 |
| Trazodone Hcl Generic | 536 | 929 | 110 | $5,628 |
| Clonazepam Generic | 458 | 552 | 79 | $4,916 |
| Bupropion Xl Bupropion Hcl | 390 | 650 | 74 | $6,816 |
| Lamotrigine Generic | 327 | 559 | 54 | $3,973 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 307 | 528 | 63 | $7,378 |
| Mirtazapine Generic | 292 | 503 | 64 | $3,656 |
| Escitalopram Oxalate Generic | 273 | 469 | 55 | $2,830 |
| Lorazepam Generic | 272 | 297 | 48 | $1,920 |
| Sertraline Hcl Generic | 269 | 533 | 63 | $1,707 |
| Duloxetine Hcl Generic | 246 | 437 | 47 | $4,416 |
| Aripiprazole Generic | 234 | 365 | 56 | $9,515 |
| Zolpidem Tartrate Generic | 188 | 202 | 26 | $1,178 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 169 | 182 | 32 | $6,569 |
Brand drugs: 261 claims; generic drugs: 7,440 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel E Chervony $2,629 ($2,629 in general payments such as food, travel and fees) from 18 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $592.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 20 | $592 |
| Neurocrine BioSciences, Inc. NBIX | 12 | $301 |
| Vanda Pharmaceuticals Inc. VNDA | 9 | $251 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $197 |
| Almatica Pharma LLC | 8 | $189 |
| Alkermes, Inc. ALKS | 10 | $186 |
| Janssen Pharmaceuticals, Inc JNJ | 6 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $126 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $115 |
| Axsome Therapeutics, Inc. AXSM | 4 | $96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.